Share on StockTwits
 

Investment analysts at JPMorgan Chase & Co. decreased their price objective on shares of Intermolecular (NASDAQ:IMI) from $12.00 to $9.00 in a note issued to investors on Friday, Stock Ratings News reports. JPMorgan Chase & Co.’s target price would suggest a potential upside of 144.57% from the stock’s previous close.

Shares of Intermolecular (NASDAQ:IMI) traded down 8.46% during mid-day trading on Friday, hitting $3.68. 441,494 shares of the company’s stock traded hands. Intermolecular has a 52 week low of $3.67 and a 52 week high of $10.69. The stock’s 50-day moving average is $4.49 and its 200-day moving average is $5.51. The company’s market cap is $169.7 million.

Intermolecular (NASDAQ:IMI) last released its earnings data on Thursday, February 6th. The company reported ($0.07) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.07). The company had revenue of $15.60 million for the quarter, compared to the consensus estimate of $15.57 million. During the same quarter last year, the company posted $0.03 earnings per share. Intermolecular’s revenue was down 10.3% compared to the same quarter last year. On average, analysts predict that Intermolecular will post $-0.11 earnings per share for the current fiscal year.

Separately, analysts at Needham & Company downgraded shares of Intermolecular from a “buy” rating to a “hold” rating in a research note to investors on Monday, January 6th.

Intermolecular, Inc (NASDAQ:IMI) is engaged in research and development and time-to-market for the semiconductor and clean-energy industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.